

Emmecell: Detailed Company Information & Corporate Profile
Contact top employees from
Emmecell
Summary
The company currently specializes in the Biotechnology area. The annual revenue of Emmecell varies between 1 and 10M. To connect with Emmecell employee register on SignalHire.
| Emmecell Website | emmecell.com |
| Social Links | |
| Industries | |
| Emmecell Headquarters address | 3475 Edison Way, Menlo Park, California, 94025 US |
| Company Size | 1-10 employees |
| Specialties | Biotechnology, Ophthalmology, Cell Therapy, Nanotechnology, Magnetic Cell Delivery, Clinical Trials, cGMP Manufacturing |
| Estimated Annual Revenue | $1 - 10M |
Competitors
Name | Founded | Type | Employees | Revenue | Funding |
|---|---|---|---|---|---|
| 2018 | Privately Held | 1 - 25 | 6M | $109.5M | |
| 2020 | - | 1-10 | 3.1M | $- | |
| - | - | 1-10 | 5.6M | $- |
Workforce Turnover
Corporate Tenure Analytics
Emmecell's workforce includes employees across a wide range of tenure levels.
20% have been with the company for 1 to 2 years20% have been with the company for 3 to 4 years40% have been with the company for 5 to 7 years20% have been with the company for more than 11 yearsContact top employees from
Emmecell
Companies Similar to Emmecell
Emmecell Corporate Information: FAQ
Emmecell operates in the Biotech industries. More details can be found on the official website: emmecell.com.
The headquarters of Emmecell are located in Menlo Park, United States.
Emmecell currently employs 1-10 people.
Emmecell's revenue is approximately 6.1M.
Well-known competitors of Emmecell include Aro Biotherapeutics, Prolocor and Scout Bio.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.







